Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort

doi:10.4254/wjh.v9.i2.106

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8383)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

442

WORD

310

HTML

3750

Figures (1-2)

161

Tables (1-3)

154

Sum=4817

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

497

Download

779

Sum=1276

Publishing Process of This Article

Item

Count

Browse

887

Download

1403

Sum=2290

Jan 18, 2017 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jan 18, 2017; 9(2): 106-113
Published online Jan 18, 2017. doi: 10.4254/wjh.v9.i2.106

Full Size Figure Download Figure

Figure 2 Twenty-eight-day survival comparing second line vasopressors in catecholamine-resistant septic shock.

Citation: Myc LA, Stine JG, Chakrapani R, Kadl A, Argo CK. Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort. World J Hepatol 2017; 9(2): 106-113
URL: https://www.wjgnet.com/1948-5182/full/v9/i2/106.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i2.106